Sex: M
Vaccine: COVID19
Symptoms: Pustular psoriasis
Clinical narrative: PUSTULAR PSORIASIS; This spontaneous report received from a patient concerned a male of unspecified age. Initial information was processed with additional information received on 17-JAN-2024 and 19-JAN-2024. The patient's height, and weight were not reported. The patient's past medical history included: heart by-pass, pustular psoriasis, and acute kidney failure. The patient was previously treated with covid-19 vaccine nrvv ad26 (JNJ 78436735) (dose number in series 1) for covid-19 prophylaxis. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included diltiazem. On an unspecified date, the patient experienced acute kidney failure (dose number in series 2), and pustular psoriasis (dose number in series 2). Treatment medications (dates unspecified) included: ciclosporin, guselkumab, and spesolimab. The consumer stated pustular psoriasis was caused by the Covid vaccine and that he got the pustular psoriasis after his second dose of the Covid vaccine. The consumer stated that he was initially treated with Cyclosporine, which was usually used in rejection of transplants, but it also damages the kidneys. The consumer stated that he then had acute kidney failure, so he was placed on a medication called spesolimab. The consumer stated that his pustular psoriasis got worse, and he was placed back on the cyclosporine. The consumer stated that he had continued the cyclosporine since starting the guselkumab so he was not sure which one was working at this point. The consumer stated that he had a heart by-pass and was also on Diltiazem and it causes extreme damage to the kidneys, and no one investigated that, so he went off the Cyclosporine and was going to see if the guselkumab was really working or if it was the cyclosporine. The consumer stated that the acute kidney damage was serious, and his doctor also took him off the Diltiazem and since the condition was so dire and serious, he really wanted to give the guselkumab every opportunity to work and see if it was working for him since he needed to be off the cyclosporine. The consumer stated that he was even willing to take a second injection to be sure that he gets this dose and take a chance that he ends up taking too much guselkumab to be sure that he gets the full dose.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pustular psoriasis was not reported. This report was non-serious. This case, involving the same patient is linked to 20240141349. This report was associated with a product quality complaint: 90000310206, and 90000310205. Complaint Number 90000310206: Voided. This report was generated for a report of medical adverse events related to a Covid-19 vaccination. There is no indication which vaccine the patient received and no product quality issue described in regards to the vaccine in the information reported. Related record 90000310205 captures report for TREMFYA. This case, involving the same patient is linked to 20240141349.